Home » Stocks » Beyond Air

Beyond Air, Inc. (XAIR)

Stock Price: $7.07 USD 0.26 (3.82%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 119.07M
Revenue (ttm) 1.39M
Net Income (ttm) 20.99M
Shares Out 16.45M
EPS (ttm) -1.53
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $7.07
Previous Close $6.81
Change ($) 0.26
Change (%) 3.82%
Day's Open 6.90
Day's Range 6.70 - 7.20
Day's Volume 361,171
52-Week Range 3.45 - 12.50

More Stats

Market Cap 119.07M
Enterprise Value 98.48M
Earnings Date (est) Aug 12, 2020
Ex-Dividend Date n/a
Shares Outstanding 16.45M
Float 10.81M
EPS (basic) -1.78
EPS (diluted) -1.53
FCF / Share -1.33
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.46M
Short Ratio 6.13
Short % of Float 9.88%
Beta -0.61
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 85.66
PB Ratio 9.51
Revenue 1.39M
Operating Income -18.14M
Net Income 20.99M
Free Cash Flow -15.29M
Net Cash 20.59M
Net Cash / Share 1.22
Gross Margin 100.00%
Operating Margin -1,305.08%
Profit Margin 1,472.20%
FCF Margin -1,100.18%
ROA -61.52%
ROE -180.33%
ROIC 397.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(87.41% upside)
Current: 7.07
Target: 13.25
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth-82%---
Gross Profit1.397.72--
Operating Income-18.14-3.06-11.07-2.33
Net Income20.99-6.56-18.043.72
Shares Outstanding11.518.506.001.45
Earnings Per Share-1.78-0.77-3.01-2.69
Operating Cash Flow-15.251.34-7.12-0.69
Capital Expenditures-0.04-0.06-0.240.01
Free Cash Flow-15.291.28-7.36-0.68
Cash & Equivalents25.477.901.810.01
Total Debt4.880.260.033.31
Net Cash / Debt20.597.641.78-3.31
Book Value18.094.02-8.38-4.70
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Beyond Air, Inc.
Country United States
Employees 18
CEO Steven A. Lisi

Stock Information

Ticker Symbol XAIR
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: XAIR


Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) delivery systems to treat respiratory tract infections and other diseases. Its NO delivery systems are used for the treatment of pulmonary hypertension of the newborn, bronchiolitis, and nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. The company is based in Garden City, New York.